deltatrials
Completed PHASE3 INTERVENTIONAL 2-arm NCT02477839

Efficacy and Safety of Lacosamide as Adjunctive Therapy in Subjects ≥1 Month to <4 Years With Partial-onset Seizures

A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Investigate the Efficacy and Safety of Lacosamide as Adjunctive Therapy in Subjects With Epilepsy >=1 Month to <4 Years of Age With Partial-Onset Seizures

Sponsor: UCB BIOSCIENCES, Inc.

Conditions Epilepsy With Partial-onset Seizures
Interventions Lacosamide Placebo
Updated 38 times since 2017 Last updated: Jun 30, 2021 Started: Jun 5, 2015 Primary completion: May 28, 2020 Completion: May 28, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Epilepsy With Partial-onset Seizures, this trial is completed. The trial is conducted by UCB BIOSCIENCES, Inc. and has accumulated 38 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Jun 2017 · 4 months · monthly snapshot~Jun 2017 – ~Jul 2017 · 30 days · monthly snapshot~Jul 2017 – ~Nov 2017 · 4 months · monthly snapshot~Nov 2017 – ~Dec 2017 · 30 days · monthly snapshot~Dec 2017 – ~May 2018 · 5 months · monthly snapshot~May 2018 – ~Jun 2018 · 31 days · monthly snapshot~Jun 2018 – ~Jul 2018 · 30 days · monthly snapshot~Jul 2018 – ~Aug 2018 · 31 days · monthly snapshot~Aug 2018 – ~Sep 2018 · 31 days · monthly snapshot~Sep 2018 – ~Oct 2018 · 30 days · monthly snapshot~Oct 2018 – ~Nov 2018 · 31 days · monthly snapshot~Nov 2018 – ~Dec 2018 · 30 days · monthly snapshot~Dec 2018 – ~Jan 2019 · 31 days · monthly snapshot~Jan 2019 – ~Feb 2019 · 31 days · monthly snapshot~Feb 2019 – ~Mar 2019 · 28 days · monthly snapshot~Mar 2019 – ~Apr 2019 · 31 days · monthly snapshot~Apr 2019 – ~May 2019 · 30 days · monthly snapshot~May 2019 – ~Jun 2019 · 31 days · monthly snapshot~Jun 2019 – ~Jul 2019 · 30 days · monthly snapshot~Jul 2019 – ~Aug 2019 · 31 days · monthly snapshot~Aug 2019 – ~Sep 2019 · 31 days · monthly snapshot~Sep 2019 – ~Oct 2019 · 30 days · monthly snapshot~Oct 2019 – ~Nov 2019 · 31 days · monthly snapshot~Nov 2019 – ~Dec 2019 · 30 days · monthly snapshot~Dec 2019 – ~Jan 2020 · 31 days · monthly snapshot~Jan 2020 – ~Feb 2020 · 31 days · monthly snapshot~Feb 2020 – ~Mar 2020 · 29 days · monthly snapshot~Mar 2020 – ~Apr 2020 · 31 days · monthly snapshot~Apr 2020 – ~Jul 2020 · 3 months · monthly snapshot~Jul 2020 – ~Dec 2020 · 5 months · monthly snapshot~Dec 2020 – ~Jan 2021 · 31 days · monthly snapshot~Jan 2021 – ~Sep 2021 · 8 months · monthly snapshot~Sep 2021 – ~Jul 2024 · 34 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – ~Oct 2025 · 30 days · monthly snapshot~Oct 2025 – present · 9 months · monthly snapshot

Change History

38 versions recorded

  1. Oct 2025 — Present [monthly]

    Completed PHASE3

  2. Sep 2025 — Oct 2025 [monthly]

    Completed PHASE3

  3. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE3

  4. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  5. Sep 2021 — Jul 2024 [monthly]

    Completed PHASE3

▶ Show 33 earlier versions

  1. Jan 2021 — Sep 2021 [monthly]

    Completed PHASE3

  2. Dec 2020 — Jan 2021 [monthly]

    Completed PHASE3

  3. Jul 2020 — Dec 2020 [monthly]

    Completed PHASE3

    Status: Active Not Recruiting → Completed

  4. Apr 2020 — Jul 2020 [monthly]

    Active Not Recruiting PHASE3

    Status: Recruiting → Active Not Recruiting

  5. Mar 2020 — Apr 2020 [monthly]

    Recruiting PHASE3

  6. Feb 2020 — Mar 2020 [monthly]

    Recruiting PHASE3

  7. Jan 2020 — Feb 2020 [monthly]

    Recruiting PHASE3

  8. Dec 2019 — Jan 2020 [monthly]

    Recruiting PHASE3

  9. Nov 2019 — Dec 2019 [monthly]

    Recruiting PHASE3

  10. Oct 2019 — Nov 2019 [monthly]

    Recruiting PHASE3

  11. Sep 2019 — Oct 2019 [monthly]

    Recruiting PHASE3

  12. Aug 2019 — Sep 2019 [monthly]

    Recruiting PHASE3

  13. Jul 2019 — Aug 2019 [monthly]

    Recruiting PHASE3

  14. Jun 2019 — Jul 2019 [monthly]

    Recruiting PHASE3

  15. May 2019 — Jun 2019 [monthly]

    Recruiting PHASE3

  16. Apr 2019 — May 2019 [monthly]

    Recruiting PHASE3

  17. Mar 2019 — Apr 2019 [monthly]

    Recruiting PHASE3

  18. Feb 2019 — Mar 2019 [monthly]

    Recruiting PHASE3

  19. Jan 2019 — Feb 2019 [monthly]

    Recruiting PHASE3

  20. Dec 2018 — Jan 2019 [monthly]

    Recruiting PHASE3

  21. Nov 2018 — Dec 2018 [monthly]

    Recruiting PHASE3

  22. Oct 2018 — Nov 2018 [monthly]

    Recruiting PHASE3

  23. Sep 2018 — Oct 2018 [monthly]

    Recruiting PHASE3

  24. Aug 2018 — Sep 2018 [monthly]

    Recruiting PHASE3

  25. Jul 2018 — Aug 2018 [monthly]

    Recruiting PHASE3

  26. Jun 2018 — Jul 2018 [monthly]

    Recruiting PHASE3

  27. May 2018 — Jun 2018 [monthly]

    Recruiting PHASE3

  28. Dec 2017 — May 2018 [monthly]

    Recruiting PHASE3

  29. Nov 2017 — Dec 2017 [monthly]

    Recruiting PHASE3

  30. Jul 2017 — Nov 2017 [monthly]

    Recruiting PHASE3

  31. Jun 2017 — Jul 2017 [monthly]

    Recruiting PHASE3

  32. Feb 2017 — Jun 2017 [monthly]

    Recruiting PHASE3

  33. Jan 2017 — Feb 2017 [monthly]

    Recruiting PHASE3

    First recorded

Jun 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • UCB BIOSCIENCES, Inc.
Data source: UCB Pharma

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Aguascalientes, Mexico , Athens, Greece , Bangkok, Thailand , Beijing, China , Belgrade, Serbia , Birmingham, United States , Bratislava, Slovakia , Bucharest, Romania , Budapest, Hungary , Cebu, Philippines and 60 more locations